AI assistant
Sending…
FATE THERAPEUTICS INC — Director's Dealing 2019
Jul 17, 2019
34091_dirs_2019-07-17_83bbe9d2-72b1-4c6c-a5ad-e219ef644191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2019-07-15
Reporting Person: Agarwal Shefali (Director)
More from FATE THERAPEUTICS INC
Report Publication Announcement
2026
Jun 4
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 24
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 12